Effects on immune cell function and phenotype following treatment with blinatumomab in children with relapsed b-cell precursor acute lymphoblastic leukaemia.
Phase of Trial: Phase II
Latest Information Update: 13 Aug 2014
At a glance
- Drugs Blinatumomab (Primary)
- Indications Acute lymphoblastic leukaemia
- Focus Pharmacodynamics
- 13 Aug 2014 New trial record